Stay updated on Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2. The page still displays a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-19T14:15:22.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T14:52:03.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study content and navigation with a minimal header. This indicates the record is currently inaccessible due to access restrictions.
    Difference
    20%
    Check dated 2026-09-21T22:21:58.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page shows a new revision tag (v3.6.6) replacing the previous v3.6.5. This indicates a minor update to the page’s software or formatting rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-08-31T18:28:02.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5 for the study record, indicating a new version of the page content.
    Difference
    0.0%
    Check dated 2026-08-10T12:40:37.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    The page's revision tag has been updated from v3.6.3 to v3.6.4, indicating a new build of the page. This update appears to be an internal software revision without changes to the study details or how the page presents information to users.
    Difference
    0.0%
    Check dated 2026-07-27T05:23:10.000Z thumbnail image

Stay in the know with updates to Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial page.